Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 355-360

  lo Giudice, Giuseppe ^a   de Belvis, Valentina ^b   Tavolato, Marco ^a   Galan, Alessandro ^a  

^a S ANTONIO HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Central serous chorioretinopathy; Indocyanine green angiography; Neurosensory detachment; Transpupillary thermotherapy

Indexed keywords

ADULT; ARTICLE; CENTRAL SEROUS RETINOPATHY; CHRONIC SEROUS MACULA DETACHMENT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RETINA FOVEA; RETINA MACULOPATHY; SOMATOSENSORY CORTEX; THERAPY EFFECT; TRANSPUPILLARY THERMOTHERAPY; VISUAL ACUITY;

EID: 79952820564     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S16014     Document Type: Article

References (33)

1. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium:II Idiopathic central serous choriodopathy. Am J Ophthalmol. 1967; 63(3): Suppl:1-139.
2. Schatz H, Madeira D, Johnson RN, McDonald HR. Central serous chorioretinopathy occurring in patients 60 years of age and older. Ophthalmology. 1992;99(1):63-67.
3. Ciardella AP, Guyer DR, Spitznas M, Yannuzzi LA. Central serouschorioretinopathy. Retina. 3rd ed. St Louis: Mosby; 2001:1153-1181.
4. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 4th ed. St Louis: Mosby; 1997:52-70.
5. Hussain D, Gass JD. Idiopathic central serous chorioretinopathy. Indian J Ophthalmol. 1998;46(3):131-137.
6. Lafaut BA, Salati C, Priem H, De Laey JJ. Indocyanine green angiographyis of value for the diagnosis of chronic serous chorioretinopathy in elderly patients. Graefes Arch Clin Exp Ophthalmol. 1998;236(7): 513-521.
7. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol. 1996;121(1):26-34.
8. Yap EY, Robertson DM. Long-term outcome of central serous chorioretinopathy. Arch Ophthalmol. 1996;114 (6):689-692.
9. Schatz H, Madeira D, Johnson RN, McDonald HR. Central serouschorioretinopathy occurring in patients 60 years of age and older. Ophthalmology. 1992;99(1):63-67.
10. Klein ML, van Burskirk EM, Freidman E, et al. Experiences with non-treatment of central serous chorioretinopathy. Arch Ophthalmol.1974;91:247-250.
11. Bujarborua D. Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmol Scand. 2001; 79(4): 417-421.
12. Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term follow-up of centralserous chorioretinopathy. Br J Ophthalmol. 1984; 68(11):815-820.
13. Robertson DM, Ilstrup D. Direct, indirect and sham laser photocoagulation in the management of central serous chorioretinopathy. Am JOphthalmol. 1983;95(4):457-466.
14. Yannuzzi LA, Slakter JS, Kaufman SR, Gupta K. Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol. 1992; 2(3): 103-114.
15. Parodi MB, Pozzo SDA, Ravalico G. Photodynamic therapy in chroniccentral serous chorioretinopathy. Retina. 2003; 23(2):235-237.
16. Miller JW, Schmidt-Erfurth U, Sickenberg M, et al. Photodynamictherapy with verteporfin for choroidal neovascularization caused byage-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol. 1999; 117(9):1161-1173.
17. Ruiz-Moreno JM, Lugo FL, Armadá F, et al. Photodynamic therapy forchronic central serous chorioretinopathy. Acta Ophthalmol. 2009; 88(3):371-376.
18. Lee PY, Kim KS, Lee WK. Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy. Jpn J Ophthalmol. 2009;53(1): 52-56.
19. Yaman A, Arikan G, Saatci AO, Cingil G. Choroidal neovascularization following photodynamic therapy in a patient with chronic central serous chorioretinopathy. Bull Soc Belge Ophtalmol. 2007; (303):69-73.
20. Myint K, Armbrecht AM, Mon S, Dhillon B. Transpupillary thermotherapy for the treatment of occult CNV in age-related macular degeneration: a prospective randomized controlled pilot study. Acta Ophthalmol Scand. 2006; 84(3):328-332.
21. Parrozzani R, Boccassini B, De Belvis V, et al. Long-term outcome of transpupillary thermotherapy as primary treatment of selected choroidalmelanoma. Acta Ophthalmol. 2008; 87(7):789-792.
22. Forte R, Cennamo G. Transpupillary thermotherapy of choroidal melanomas. J Fr Ophtalmol. 2008; 31(3):279-281.
23. Vianna RN, Fernandes L, Muralha A, et al. Transpupillary thermotherapy in the treatment of circumscribed choroidal hemangiomas. Int Ophthalmol. 2004; 25(2):117-121.
24. Hussain N, Khanna R, Hussain A, Das T. Transpupillary thermotherapy for chronic central serous chorioretinopathy. Graefes Arch Clin ExpOphthalmol. 2006; 244(8):1045-1051.
25. Shukla D, Kolluru C, Vignesh TP, et al. Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy. Eye. 2008; 22(1):100-106.
26. Spitznas M. Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmol. 1986; 224(4): 321-324.
27. Marmor MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1988; 226(6):548-552.
28. Yao XY, Marmor MF. Induction of serous retinal detachment in rabbit eyes by pigment epithelial and choriocapillary injury. Arch Ophthalmol.1992;110(4):541-546.
29. Dohrmann J, Lommatzsch A, Spital G, Pauleikhoff D. Pathogenesis of central serous chorioretinopathy: angiographic and electro physiological studies. Ophthalmologe. 2001;98(11):1069-1073.
30. Reichel E, Berrocal AM, Ip M, et al. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology. 1999;106(10):1908-1914.
31. Ming Y, Algvere PV, Odergren A, et al. Subthreshold transpupillarythermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina. Invest Ophthalmol Vis Sci. 2004;45(6):1969-1974.
32. Desmettre T, Maurage CA, Mordon S. Transpupillary thermotherapy (TTT) with short duration laser exposures induce heat shock protein (HSP) hyperexpression on choroidoretinal layers. Lasers Surg Med.2003; 33(2):102-107.
33. Desmettre T, Maurage CA, Mordon S. Heat shock protein hyperexpression on chorioretinal layers after transpupillary thermotherapy. Invest Ophthalmol Vis Sci. 2001; 42(12):2976-2980.